Abiopharma

News list

Revankar Shriram 🔴 sold 3.0K shares of Dolby Laboratories, Inc. (DLB) at $62.71 Transaction Date: Aug 14, 2026 | Filing ID: 355688

Full text

News bot Aug. 18, 2026, 9:14 p.m.
🔍 Revankar Shriram (Executive)

Company: Dolby Laboratories, Inc. (DLB)

Report Date: 2026-08-14
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 3,000
Detailed Transactions and Holdings:
- Sold 3,000 shares of Class A Common Stock at $62.71 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: false | shares_owned_after: 73,274.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Shares held following the reported transactions include 46,938 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.